Pasithea Therapeutics Corp (KTTA)
6.40
-0.15
(-2.29%)
USD |
NASDAQ |
May 24, 16:00
6.41
+0.01
(+0.16%)
After-Hours: 20:00
Pasithea Therapeutics Shareholders Equity (Quarterly): 19.88M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 19.88M |
| December 31, 2023 | 23.40M |
| September 30, 2023 | 28.37M |
| June 30, 2023 | 35.59M |
| March 31, 2023 | 39.14M |
| December 31, 2022 | 42.50M |
| September 30, 2022 | 46.79M |
| Date | Value |
|---|---|
| June 30, 2022 | 51.47M |
| March 31, 2022 | 49.98M |
| December 31, 2021 | 51.42M |
| September 30, 2021 | 16.48M |
| June 30, 2021 | 0.4701M |
| March 31, 2021 | 0.9007M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
0.4701M
Minimum
Jun 2021
51.47M
Maximum
Jun 2022
31.26M
Average
35.59M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 14.30M |
| AIM ImmunoTech Inc | 4.826M |
| IGC Pharma Inc | 9.053M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Protalix BioTherapeutics Inc | 29.79M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.41M |
| Total Liabilities (Quarterly) | 2.525M |